Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Commercialization
Sort By
Newest First
1 / 1
Drug Development
REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
REGENXBIO
PR-01-25-NI-12
Jan 14, 2025
Clinical Trials
Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Therapies Clinical Trials and Commercialization
Chime Biologics
PR-01-25-NI-01
Jan 03, 2025
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10
Sep 17, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02
Mar 08, 2024
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
Dongyoung Park
Samsung Biologics
PAO-03-24-CL-01
Mar 04, 2024
New Facility
Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin
Synbiotic Health
PR-M11-22-02
Nov 02, 2022
Commercialization
Evolve Biologics Provides Business Update on Progress Toward Commercialization of Innovative Plasmacap EBA® Technology
Evolve Biologics
PR-M11-20-047
Mar 10, 2021
Partnership
Facilitating the Commercialization of Disruptive Industrial Life Science Technologies
Gustavo Mahler, Ph.D.; Daniella Kranjac
Dynamk Capital
PAP-Q1-20-CL-031
Mar 19, 2020
Genfit Gets New CEO as it Moves to Approval and Commercialization Stage
Pharma's Almanac
PA2119
Sep 11, 2019
Series B Financing
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
Purigen Biosystems
PR-M06-19-NI-022
Jun 17, 2019
Commercialization
Supporting Commercialization with Specialized Technologies
Joseph Szczesiul
UPM Pharmaceuticals
PAP-Q2-2019-CL-034
May 24, 2019
Orphan Drug Development
Navigating the Road to Successful Orphan Drug Commercialization and Launch
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-2019-NI-003
May 24, 2019
AAV and LV Vectors
Supporting AAV and Lentiviral Vector Development and Commercialization
James Brown, Ph.D.
Aldevron
PAP-Q2-2019-CL-005
May 24, 2019
Commercialization
Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazol
Pulmatrix
PR-M04-19-NI-023
Apr 05, 2019
Investment
Successful Funding Round Could Lead to Commercialization of Bio-integrative Bone Pin
Pharma's Almanac
PAO-M03-19-NI-023
Mar 12, 2019
HPAPI
Investing in the Future of Potent Compounds
Frederic Desdouits
Seqens
PAP-Q1-2019-CL-028
Mar 12, 2019
Pre-Natal
NX Prenatal and Milu Labs Announce Strategic Collaboration to Commercialize Exosome-Based Preterm Birth Risk Test in Asia
NX Prenatal
PR-M01-19-NI-059
Jan 21, 2019
Regulatory
Reducing Time to Market with Targeted Regulatory Affairs Support
Maryse Phan
Servier
PAO-06-18-CL-003
Jun 20, 2018
Drug Development
PharmaFluidics Raises 7.3 Million Euro to Expand Commercialization of Novel Micro-Chip Device for Biomarker, Diagnostics and Drug Development Applications
PharmaFluidics
PR-M01-18-NI-044
Jan 16, 2018
1 / 1
